Drug-Resistant Tuberculosis: Challenges and Progress
- PMID: 27208770
- PMCID: PMC4876017
- DOI: 10.1016/j.idc.2016.02.010
Drug-Resistant Tuberculosis: Challenges and Progress
Abstract
Antimicrobial resistance is a natural evolutionary process, which in the case of Mycobacterium tuberculosis is based on spontaneous chromosomal mutations, meaning that well-designed combination drug regimens provided under supervised therapy will prevent the emergence of drug-resistant strains. Unfortunately, limited resources, poverty, and neglect have led to the emergence of drug-resistant tuberculosis throughout the world. The international community has responded with financial and scientific support, leading to new rapid diagnostics, new drugs and regimens in advanced clinical development, and an increasingly sophisticated understanding of resistance mechanisms and their application to all aspects of TB control and treatment.
Keywords: Antimicrobial resistance; Drug-resistant tuberculosis; Mycobacterium tuberculosis.
Copyright © 2016 Elsevier Inc. All rights reserved.
References
-
- Caminero JA. Multidrug-resistant tuberculosis: Epidemiology, risk factors and case finding. Int J Tuberc Lung Dis. 2010;14(4):382–90. - PubMed
-
- Antimicrobial resistance: Tackling a crisis for the health and wealth of nations. Available at: http://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tac....
-
- World Health Organization. Global tuberculosis report 2014. Geneva: World Health Organization; 2014.
-
- Division of Tuberculosis Elimination, Centers for Disease Control and Prevention; Reported tuberculosis in the united states. Available at: http://www.cdc.gov/tb/statistics/
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
